PLX icon

Protalix BioTherapeutics

66 hedge funds and large institutions have $17.9M invested in Protalix BioTherapeutics in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.82M
Puts
$838K
Net Calls
Net Calls Change

Top Buyers

1 +$5.05M
2 +$1.46M
3 +$1.1M
4
Marshall Wace
Marshall Wace
United Kingdom
+$824K
5
Northern Trust
Northern Trust
Illinois
+$726K

Top Sellers

1 -$1.1M
2 -$494K
3 -$444K
4
Two Sigma Investments
Two Sigma Investments
New York
-$278K
5
Millennium Management
Millennium Management
New York
-$131K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.28M
2
$1.46M
3
$1.32M
4
$1.12M
5
$1.1M
6
$726K
7
$560K
8
$552K
9
$524K
10
$461K
11
$342K
12
$331K
13
$318K
14
$294K
15
$275K
16
$264K
17
$257K
18
$231K
19
$220K
20
$177K
21
$142K
22
$132K
23
$120K
24
$110K
25
$109K